About ALLO

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, Allogene is developing a pipeline of "off-the-shelf" CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients. AlloCAR T cell therapies are engineered from cells of healthy donors, which is intended to allow for creation of inventory for on demand use in patients. This approach is designed to eliminate the need to create personalized therapy from a patient's own cells, simplify manufacturing, and reduce the time patients must wait for CAR T cell treatment. The Allogene portfolio includes rights to 16 pre-clinical CAR T cell therapy targets and UCART19, an AlloCAR T therapy candidate currently in Phase 1 sponsored by Servier for the treatment of relapsed/refractory acute lymphoblastic leukemia (ALL).
Primary Exchange: NASDAQ
SIC Biological Products, (No Diagnostic Substances)
NAICS Biological Product (except Diagnostic) Manufacturing

ALLO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
LABU Direxion Daily S&P Biotech Bull 3X Shares 659.9 M 6.59918E+08 131 131 0.07% 0.000696206 1.6 M 1595460
RXL ProShares Ultra Health Care 104.7 M 1.04673E+08 140 140 0.01% 6.22695E-05 14 K 13572
URTY ProShares UltraPro Russell2000 94.2 M 9.42E+07 2,008 2008 0.01% 6.85531E-05 21 K 20734
UWM ProShares Ultra Russell2000 205.3 M 2.05261E+08 2,008 2008 0.01% 8.48268E-05 40 K 40041
FPX First Trust US Equity Opportunities ETF 1.1 B 1.1125E+09 100 100 0.23% 0.0023 2.6 M 2558750
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.02% 0.000203074 418 K 418162
ITOT iShares Core S&P Total U.S. Stock Market ETF 19.6 B 1.96269E+10 3,548 3548 0.0% 0 360 K 359757
IWM iShares Russell 2000 ETF 43.3 B 4.3328E+10 1,996 1996 0.03% 0.0003 12.1 M 1.20693E+07
IWN iShares Russell 2000 Value ETF 9.4 B 9.41302E+09 1,363 1363 0.01% 0.0001 953 K 953465
IWO iShares Russell 2000 Growth ETF 9.3 B 9.26839E+09 1,234 1234 0.04% 0.0004 4.1 M 4083590
IWV iShares Russell 3000 ETF 9.4 B 9.43267E+09 2,938 2938 0.0% 0 171 K 171226
IYH iShares U.S. Healthcare ETF 2.1 B 2.0642E+09 129 129 0.01% 0.0001 295 K 294937
IYY iShares Dow Jones U.S. ETF 1.2 B 1.2236E+09 1,225 1225 0.0% 0 22 K 21905
VB Vanguard Small-Cap ETF 24.3 B 2.43E+10 1,376 1376 0.02% 0.0002 5.0 M 5009520
VBK Vanguard Small-Cap Growth ETF 8.7 B 8.7E+09 619 619 0.02% 0.00022 1.9 M 1886500
VBR Vanguard Small-Cap Value ETF 13.1 B 1.31E+10 840 840 0.02% 0.0002 2.7 M 2689520
VTHR Vanguard Russell 3000 ETF 433.4 M 4.334E+08 2,965 2965 0.0% 2E-05 10 K 9593
VTI Vanguard Total Stock Market ETF 109.6 B 1.096E+11 3,588 3588 0.0% 2E-05 2.7 M 2710060
VTWG Vanguard Russell 2000 Growth ETF 296.4 M 2.964E+08 1,245 1245 0.05% 0.0005 148 K 148233
VTWO Vanguard Russell 2000 ETF 1.5 B 1.5E+09 2,006 2006 0.03% 0.00031 471 K 471126
VTWV Vanguard Russell 2000 Value ETF 245.2 M 2.452E+08 1,371 1371 0.01% 0.00011 28 K 27839
VXF Vanguard Extended Market ETF 6.8 B 6.8E+09 3,242 3242 0.01% 0.00012 857 K 857299